papaverine has been researched along with moxisylyte in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amer, M; Schouman, M | 1 |
| Buvat, J; Buvat-Herbaut, M; Lemaire, A; Marcolin, G | 2 |
| Alexandre, L; Benoit, G; Bensadoun, H; Jardin, A; Puech, A | 1 |
| Porst, H | 1 |
| Gingell, JC | 1 |
| Boiteau, F; Boyer, F; Dizien, O; Laffont, I; Lebib Ben Achour, S | 1 |
| Bonan, I; Chéhensse, C; Chochina, L; Damphousse, M; Giuliano, F; Manunta, A; Naudet, F | 1 |
3 review(s) available for papaverine and moxisylyte
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New developments in self-injection therapy for erectile dysfunction.
Topics: Alprostadil; Calcitonin Gene-Related Peptide; Chlorpromazine; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Injections; Male; Moxisylyte; Papaverine; Patient Satisfaction; Phentolamine; Self Administration; Sympatholytics; Treatment Outcome; Vasoactive Intestinal Peptide; Vasodilator Agents | 1998 |
Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Penile Erection; Prospective Studies; Retrospective Studies; Spinal Cord Injuries; Vasodilator Agents | 2016 |
3 trial(s) available for papaverine and moxisylyte
| Article | Year |
|---|---|
Safety of intracavernous injections using an alpha-blocking agent.
Topics: Adult; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Moxisylyte; Papaverine; Penile Erection; Self Administration; Vibration | 1989 |
[Treatment of impotence with intracavernous auto-injections: moxisylyte diminishes the risks compared to papaverine].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Moxisylyte; Papaverine; Penile Induration; Penis; Priapism; Self Administration; Time Factors; Treatment Outcome | 1993 |
[Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Patient Satisfaction; Spinal Cord Injuries; Vasodilator Agents | 2001 |
3 other study(ies) available for papaverine and moxisylyte
| Article | Year |
|---|---|
[Value of the visual stimulation test (VST) as initial paraclinical test in the study of erectile impotence. Classification of psychogenic impotence using computerized rigidimetry. The value of thymoxamine].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Moxisylyte; Papaverine; Penile Erection; Photic Stimulation | 1989 |
[What can be expected of intracavernous injections?].
Topics: Adult; Aged; Apomorphine; Erectile Dysfunction; Humans; Injections; Injections, Subcutaneous; Male; Middle Aged; Moxisylyte; Papaverine; Penis; Vasodilator Agents | 1988 |
The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Molsidomine; Moxisylyte; Papaverine; Penile Induration; Phentolamine | 1995 |